Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

11/2/2012 (2 years ago)

Catholic Online (www.catholic.org)

Alemtuzumab is used most frequently in cancer, leukemia patients

Alemtuzumab is a new drug is the "most effective" treatment for relapsing-remitting multiple sclerosis. Researchers at the University of Cambridge say that alemtuzumab, a cancer drug, which wipes out and resets the immune system, has better results than other options. The down side? There is new concern that the drugs company that manufactures the medication is about to increase the cost of the drug as a result.

'There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems,' an editorial in the medical journal the Lancet warns.

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

11/2/2012 (2 years ago)

Published in Health

Keywords: Alemtuzumab, multiple sclerosis, leukemia, cancer, price hike


LOS ANGELES, CA (Catholic Online) - Around 100,000 people in the United Kingdom have multiple sclerosis. When the condition is diagnosed, the majority will have a form of the disease know as relapsing-remitting MS. In this strain of the condition, the symptoms can almost disappear for a time, before suddenly returning.

Alemtuzumab has shown benefits for MS in small studies. Typically used for leukemia patients, a blood cancer, controls the excess production of white blood cells. In MS patients, the dose eliminates the immune cells entirely, forcing a new immune system to be built from scratch which should not attack the nerves.

Two test trials compared the effectiveness of alemtuzumab with a first-choice drug, interferon beta-1a.

One compared the effectiveness in patients given the drug after being diagnosed, the other looked at patients given the drug after other treatments had failed.

Both showed the drug was around 50 percent more effective at preventing relapses and patients had less disability at the end of the study than when they started.

"Although other MS drugs have emerged over the last year, which is certainly good news for patients, none has shown superior effects on disability when compared to interferon except alemtuzumab," Dr. Alasdair Coles, from the University of Cambridge says.

"It is certainly the most effective MS drug, based on these clinical trials, but this is definitely not a cure," he told reporters from the BBC.

The doctor warns that there were side-effects, including developing other immune disorders.

He said he thought the drug would be most useful for patients for whom standard treatment had failed and in a "minority" of patients as a first-choice drug.

The drug has been withdrawn from the market in both Europe and the United States as the manufacturer, Genzyme, intends to have it licensed as a treatment for MS.

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.

"Finding promising treatments such as alemtuzumab are important. But so is keeping alemtuzumab accessible and affordable."

.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for July 2015
Universal:
That political responsibility may be lived at all levels as a high form of charity.
Evangelization: That, amid social inequalities, Latin American Christians may bear witness to love for the poor and contribute to a more fraternal society.



Comments


More Health

Discovery of five different kinds of prostate cancer heralded as breakthrough Watch

Image of While many men have prostate cancer, it can grow so slowly it might not cause any problems until the patient eventually dies of something else.

By Catholic Online (NEWS CONSORTIUM)

Scientists in the United Kingdom have discovered the most common cancer among men can be classified into five types, depending on its DNA. This is a breakthrough in prostate cancer research, and once the type of cancer is identified, the patient's survival rate ... continue reading


8-year-old boy becomes youngest double-hand transplant patient Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

Surgeons believe 8-year-old Zion Harvey is the youngest to receive a double-hand transplant. The boy lost both of his hands over a severe infection years ago and opted to go through a transplant with the support of his parents. After the initial success of the ... continue reading


World's first malaria vaccine wins approval from European drug regulators Watch

Image of Mosquirix must first win agreement from African governments as the vaccine only offers only partial protection.

By Catholic Online (NEWS CONSORTIUM)

The world's first malaria vaccine is a go with European drug regulators after it was recommended safe and effective for babies at risk of the 'mosquito-born disease' in Africa. LOS ANGELES, CA (Catholic Online) - Called Mosquirix, the vaccine was developed by ... continue reading


560-pound man sets out to bike across the U.S. to lose weight and save his marriage Watch

Image of [Photo by: ABC News]

By Talia Ramos (NEWS CONSORTIUM)

To try to live a healthy life, get a job and save his failing marriage, a 560-pound man decided to embark on a biking journey across the United States. He has already traveled about 90 miles since he started last month and has lost around 60 pounds during the first two ... continue reading


Catholic organization's approach to female reproductive health a 'game changer' Watch

Image of Together with his colleagues, Dr. Thomas Hilgers developed NaPro (Natural Procreative) Technology. In Omaha in 1985, they founded the Pope Paul VI Institute for the Study of Human Reproduction, and in 1999 formally created the Creighton Model FertilityCare System.

By Gabrielle Cubera, CNA EWTN News

With the hope of providing authentic and ethical health care for women, Dr. Thomas Hilgers, creator of Natural Procreative Technology, has worked for decades to establish a medical network that studies, understands, and treats the female fertility cycle. Omaha, ... continue reading


Have scientists found the key to shut off aging? New study with worms finds success Watch

Image of

By Nikky Andres (NEWS CONSORTIUM)

Scientists have uncovered how to switch off the aging process, during a recent study with worms, which could possibly lead to the process being successful in humans. MUNTINLUPA, PHILIPPINES (Catholic Online) - The new study showed that adult cells of worms shortly ... continue reading


New eye drops may soon replace cataract surgery Watch

Image of Vision could cease altogether if cataracts remain untreated. Cataracts cause more blindness worldwide than any other eye condition.

By Catholic Online (NEWS CONSORTIUM)

Inexpensive and easy to administer, a new eye drop may soon make cataract removal surgery obsolete. A frequent bane of existence that afflicts the elderly, the new drops dissolves the clumps of protein that clouds vision. LOS ANGELES, CA (Catholic Online) - Cataract ... continue reading


Superhero DNA desired by pharmaceutical researchers for new drugs Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

They don't have the ability to fly or come with laser eyes, but there are people who exist today with the "superhero" genes. Similar to the figures portrayed in media, these people have ordinary lives with extraordinary physical abilities because of uncommon biological ... continue reading


Controversial Dr. Death and his 'Destiny machine' set out to help assist the suicide of an entire volunteer audience Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

Controversial medic known as Dr. Death will try to gas a volunteer audience at the Edinburg Fringe show, which he hosts, with his updated "right-to-die machine" to showcase "a peaceful and reliable means of death." According to reports, he will invite people from the ... continue reading


Human contact with armadillos blamed for surge in leprosy cases in Florida Watch

Image of Floridians are being advised to use caution and not touch the small, cat-sized creatures.

By Catholic Online (NEWS CONSORTIUM)

Increased human contact with armadillos is being blamed for an increase in leprosy cases in Florida. The state usually sees two to 12 cases of leprosy a year. There have been nine cases in 2015 alone, which is higher than average, according to the Florida ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Exodus 40:16-21, 34-38
16 Moses did this; he did exactly as Yahweh had ... Read More

Psalm, Psalms 84:3, 4, 5-6, 8, 11
3 Even the sparrow has found a home, the swallow a ... Read More

Gospel, Matthew 13:47-53
47 'Again, the kingdom of Heaven is like a dragnet ... Read More

Saint of the Day

Saint of the Day for July 30th, 2015 Image

St. Peter Chrysologus
July 30: St. Peter Chrysologus, Bishop and Doctor of the Church ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter